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(Backgrounds and aims) Prostasin (PRSS8) is a stimulator of epithelial sodium transport. 
In this study, we evaluated alteration of prostasin expression in the inflamed mucosa of 
patients with inflammatory bowel disease (IBD) and investigated the role of prostasin in 
the gut inflammation. (Materials and methods) Prostasin expression was evaluated by 
immunohistochemical staining. Dextran sodium sulfate (DSS)-colitis was induced in 
mice lacking prostasin specifically in intestinal epithelial cells (PRSS8ΔIEC mice). 
(Results) In colonic mucosa of healthy individuals, prostasin was strongly expressed at 
the apical surfaces of epithelial cells, and this was markedly decreased in active mucosa 
of both ulcerative colitis and Crohn’s disease. DSS-colitis was exacerbated in PRSS8ΔIEC 
mice compared to control PRSS8 lox/lox mice. Toll-like receptor (TLR) 4 expression in 
colonic epithelial cells was stronger in DSS-treated PRSS8ΔIEC mice than in DSS-treated 
PRSS8 lox/lox mice. NF-B activation in colonic epithelial cells was more pronounced in 
DSS-treated PRSS8ΔIEC mice than in DSS-treated PRSS8lox/lox mice, and the mRNA 
expression of inflammatory cytokines was significantly higher in DSS-treated PRSS8ΔIEC 
mice. Broad-spectrum antibiotics treatment completely suppressed the exacerbation of 
DSS colitis in PRSS8ΔIEC mice. The mRNA expression of tight junction proteins and 
mucosal permeability assessed using FITC-dextran were comparable between DSS-
treated PRSS8 lox/lox and DSS-treated PRSS8ΔIEC mice. (Conclusion) Prostasin has an anti-
inflammatory effect via downregulation of TLR4 expression in colonic epithelial cells. 
Reduced prostasin expression in IBD mucosa is linked to be a deterioration of local anti-
inflammatory activity and may contribute to the persistence of mucosal inflammation.  
 




Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis 
(UC), is a chronic relapsing inflammatory disorders characterized by bloody diarrhea and 
abdominal pain and cramping (1-3). The exact cause of IBD remains unclear, but its 
etiology is closely associated with an excess immune response in the mucosa against 
dietary factors and gut microbes in persons with a genetic predisposition (1-3).  
 Prostasin [protease serine S1 family member 8 (PRSS8)] is an extracellular 
serine protease, expressed mainly in mammalian epithelial cells of the prostate, kidneys, 
lungs, and distal colon as a 40kDa glycosylphosphatidylinositol (GPI)-anchored 
protein(4). Prostasin is a channel activating protease which stimulates the amilorides-
sensitive epithelial sodium channels (ENaC) and provokes electrogenic sodium transport 
(5, 6). ENaC consists of , and  homologous subunits (7) and prostasin plays a crucial 
role in full activation of ENaC via proteolytic cleavage of the ENaC -subunit (4). In vivo, 
skin-specific deletion of prostasin in mice resulted in early death after birth as a 
consequence of severe dehydration, demonstrating the involvement of prostasin in the 
epidermal barrier function(8). Animals harboring mutated prostasin genes [frizzy (fr) 
mouse and hairless (frCR) rats] exhibited reduced embryonic viability, skin defects, and 
decreased ENaC activity in the colon (9). Various functions of prostasin have been 
proposed for cellular growth, morphogenesis, and sodium absorption in various organs 
including the kidney and lung (4).  
 Reduced sodium reabsorption associated with downregulated ENaC in the distal 
colon is one of the causal factors of diarrhea in IBD patients (4). In the gastrointestinal 
tract, ENaC expression is limited to the epithelial cells of the distal colon and rectum, and 
aldosterone is a potent inducer of  and  subunits of ENaC(10, 11). Increased expression 
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of ENaC in the colon induces sodium retention(7), but downregulation of ENaC leads to 
reduction of sodium reabsorption and leads to diarrhea(7). Previous studies have 
demonstrated a reduced expression of ENaC subunits in IBD patients(11, 12). Amasheh 
et al. reported that TNF- selectively suppresses expression of  and  subunits of ENaC 
and causes diarrhea in UC patients(11). Zeissig et al. also reported that sodium absorption 
via ENaC was strongly impaired even in the noninflamed colonic mucosa of CD patients 
due to reduced expression of the subunit of ENaC(12). Although dysregulation of ENaC 
has been reported to be involved in the pathophysiology of IBD, prostasin expression and 
its functional activity in IBD mucosa remain unclear.  
 The Toll-like receptors (TLRs) recognize highly conserved structural motifs 
known as pathogen-associated microbial patterns (PAMPs) widely expressed by 
microbial pathogens and initiate innate immune responses(13). Stimulation of TLRs leads 
to a variety of cellular responses including the pro-inflammatory cytokine production and 
effector cytokines that direct the development of antigen-specific acquired immunity(14). 
Among TLRs, TLR4 is predominantly activated by lipopolysaccharides (LPS), the major 
component of the outer membrane of gram-negative bacteria(14). TLR4 signaling has 
been reported to plays a crucial role in the pathophysiology of IBD(15).  
 In the present study, we investigated prostasin expression in the inflamed mucosa 
of IBD patients. We also developed mice lacking prostasin in the colonic epithelial cells 
to investigate the possible role of prostasin in the regulation of gut inflammation.   
 
Material and methods 
Tissue samples of IBD patients 
Tissue samples of the sigmoid colon were obtained by biopsy under colonoscopy or 
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surgery from patients with UC and CD. The clinical activity of IBD was determined 
according to the colitis activity index for UC(16) and the CD activity index(17). Normal 
colonic samples were obtained by biopsy under screening colonoscopy for colon cancer. 
This project was approved by the ethics committee of the Shiga University of Medical 
Science (Permission number: 30-83), and written informed consents was obtained from 
all patients. 
Animals and DSS colitis 
PRSS8-floxed (PRSS8lox/lox) mice were kindly provided by Prof. Kenichiro Kitamura 
(Faculty of Medicine, Yamanashi University, Japan) (18). Mice lacking the PRSS8 gene 
in their intestinal epithelial cells (PRSS8ΔIEC mice) were generated by crossing PRSS8 
lox/lox mice with transgenic mice that expressed Cre-recombinase driven by the villin 
promotor (villin-Cre mice: Jackson Laboratory, Bar Harbor, ME). All mice (six to eight 
weeks-old females) were housed under specific pathogen-free conditions. Mice were 
allowed free access to water and rodent chow (CE-2; CLEA Japan, Inc.). Experimental 
colitis was induced by the oral administration of 4% w/v dextran sodium sulfate (DSS: 
molecular weight 5000; Wako Pure Chemical Industries, Osaka, Japan) in tap water for 
4 days followed by tap water for 3 days. Mice were divided into four groups of PRSS8 
lox/lox mice as a control group, PRSS8ΔIEC mice, DSS-treated PRSS8 lox/lox mice (PRSS8 
lox/lox DSS mice) and DSS-treated PRSS8ΔIEC mice (PRSS8ΔIEC DSS mice) (n=5 
mice/group). This project was approved by the Research Center for Animal Life Science 
and Use Committee at the Shiga University of Medical Science (permission number: 
2017-8-7). 
Assessment of DSS induced colitis 
The severity of colitis at distal colon was evaluated using the Disease Activity Index 
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(DAI) described in a previous report(19). Histological evaluations were performed 
according to a validated scoring system (20). 
Isolation of colonic epithelial cells 
Colonic epithelial cells were isolated from distal colon according to the method 
described previously(21).  
Extraction of total RNA and real-time polymerase chain reaction (PCR) analysis 
Total RNA was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA). Real-time 
PCR was performed using the Lightcycler 480 System (Roche Applied Science, Penzberg, 
Germany) and SYBR Premix ExTaqII (TAKARA, Otsu, Japan). Expression of each target 
gene was normalized to β-actin and expressed as a ratio relative to the control group. The 
PCR primers used in this study are listed in Supplementary Table 1. 
Immunohistochemistry and immunofluorescence 
Immunohistochemical and immunofluorescence analyses were performed according to 
the method described previously (22). The used antibodies are listed in Supplementary 
Table2.  
Extraction of protein and immunoblot analysis 
Nuclear proteins were extracted from tissues or cells using the CelLytic NuCLEAR 
Extraction Kit (Sigma-Aldrich, St. Louis, MO). Cytoplasmic proteins were obtained 
according to the method described previously (23). Samples were subjected to SDS-
PAGE on a 4-20% gradient gel under reducing conditions and immunoblotting. The 
used antibodies are listed in Supplementary Table2. 
Silencing of gene expression in cultured cells 
The human colonic epithelial cell line HT-29 (ATCC, Manassas, VA) was transfected 
with small interference RNA (siRNA) specific for PRSS8 (Ambion, Carlsbad, CA) or 
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control siRNA using the Lipofectamine RNAiMAX regent (Invitrogen, Carlsbad, CA).  
In vivo epithelial permeability assay 
In vivo epithelial permeability was assessed using fluorescein isothiocyanate (FITC)-
labeled dextran according to the method described previously (24). After 4h fasting, 
mice were orally administered FITC-dextran (0.44 mg/g body weight, MW 4000; 
Sigma-Aldrich Co., St Louis, MO). After 4h, blood was collected via cardiac puncture 
and was then centrifuged for 20 min to separate serum. The fluorescein intensity at 485-
nm excitation wavelengths was measured.  
Antibiotic treatment 
PRSS8ΔIEC mice were treated with a combination of ampicillin (1mg/ml: Nacalai Tesque, 
Kyoto, Japan), vancomycin (0.5mg/ml: Nacalai Tesque), neomycin sulfate (1mg/ml: 
Nacalai Tesque) and metronidazole (1mg/ml: Nacalai Tesque) in drinking water for 
4weeks prior to DSS administration (25, 26).  
Statistical analysis 
Data were evaluated as means ± SEM. Statistical significance of the differences was 
determined by using one-way ANOVA with Bonferroni post hoc tests and the non-
parametric Mann-Whitney U-test. P < 0.05 was considered statistically significant. 
 
Results 
Mucosal expression of prostasin (PRSS8) mRNA was evaluated using the real-time PCR 
method. As shown in Fig. 1A, prostasin mRNA expression was significantly decreased in 
the active mucosa of both UC and CD patients compared to normal and/ or inactive 
mucosa. This finding was confirmed by immunohistochemical staining (Fig. 1B). In 
normal colonic mucosa, prostasin was strongly expressed at the apical surfaces of colonic 
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epithelial cells. However, this staining was markedly decreased in active mucosa of UC 
and CD patients.  
 To investigate the role of prostasin in gut inflammation, we evaluated DSS colitis 
developed in mice in which prostasin is specifically deleted in intestinal epithelial cells 
(PRSS8ΔIEC mice). In these mice, intestinal epithelial cell-specific prostasin deletion was 
confirmed at the mRNA and protein levels (Supplementary Fig. 1). Compared to PRSS8 
lox/lox mice, PRSS8ΔIEC mice exhibited no changes in appearance, body weight gain or 
water intake. Some PRSS8ΔIEC mice presented soft stool, but it was not severe. Under DSS 
load, body weight loss between days 5 to day 7 was significantly higher in PRSS8ΔIEC 
mice than in control PRSS8 lox/lox mice (Fig. 2A). Disease activity index on day 7 was 
significantly higher in DSS-treated PRSS8ΔIEC mice than in DSS-treated PRSS8 lox/lox mice 
(Fig.2B). There were no histological changes in colonic mucosa of PRSS8ΔIEC mice (Fig. 
2C), but DSS treatment induced more severe inflammatory changes, such as epithelial 
disruption and inflammatory cell infiltration, in PRSS8ΔIEC mice than in PRSS8 lox/lox mice 
(Fig. 2C). The histological colitis score was significantly higher in DSS-treated 
PRSS8ΔIEC mice than in DSS-treated PRSS8 lox/lox mice (Fig. 2D). Thus, targeted deletion 
of prostasin in intestinal epithelial cells exacerbated DSS colitis, suggesting a protective 
role of prostasin in gut inflammation.   
 TLR4 signaling has been reported to play a dominant role in the pathophysiology 
of IBD and DSS-colitis. In addition, it has been recently demonstrated that prostasin 
regulates TLR signaling in hepatocytes (18). Based on these findings, we addressed TLR4 
expression in PRSS8ΔIEC mice. Histological and immunoblot analyses demonstrated that 
TLR4 expression was weakly expressed in colonic epithelial cells of control PRSS8 lox/lox 
mice, and this was strongly increased in PRSS8ΔIEC mice (Fig. 3A and B), indicating that 
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prostasin is a negative regulator for TLR4 expression. This was supported by the 
observations in DSS-treated PRSS8ΔIEC mice. DSS treatment enhanced TLR4 expression 
in colonic epithelial cells of PRSS8 lox/lox mice and PRSS8ΔIEC mice (Fig. 3A and B) and 
this effect was much stronger in PRSS8ΔIEC mice (Fig. 3A and B).  
NF-B is a master transcription factor of inflammatory responses and its 
activation is closely associated with TLR4 signaling (27). In this study, we evaluated NF-
B activation by cytoplasmic accumulation of phosphorylated- (p-)IB and 
translocation of NF-B p65 into the nucleus. Reflecting the changes in TLR4 expression 
in PRSS8ΔIEC mice, immunoblot analyses showed that NF-B activation in colonic 
epithelial cells was much stronger in DSS-treated PRSS8ΔIEC mice than in DSS-treated 
PRSS8lox/lox mice (Fig. 3C). The mRNA expression of inflammatory cytokines (TNF, IL-
1, IL-6 and CXCL1) which are induced through NF-B activation was significantly 
higher in DSS-treated PRSS8ΔIEC mice than in DSS-treated PRSS8 lox/lox mice (Fig. 3D). 
These findings suggest that deletion of prostasin induced TLR4 expression in colonic 
epithelial cells and exacerbated colitis as a consequence of enhanced TLR4 signaling.  
 Interaction between PRSS8 and TLR4 expression was investigated in vitro. In 
the colonic epithelial cell line HT-29, PRSS8 mRNA expression was silenced by prostasin 
(PRSS8)-specific siRNA. As shown in Fig. 4A, immunoblot analysis revealed that 
prostasin protein expression was completely depleted in HT-29 cells transfected with 
PRSS8-specific siRNA. Prostasin deletion induced a marked enhancement of TLR4 
protein expression (Fig. 4A left panel), although TLR4 mRNA was similarly expressed 
in control HT-29 cells and prostasin-depleted cells (Fig.4A right panel). Induction of 
TLR4 was supported by the findings of NF-B activation in prostasin-depleted cells. LPS 
induced cytoplasmic accumulation of phosphorylated (p)-IB and translocation of NF-
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B p65 into the nucleus (Fig. 4B), and these responses were markedly enhanced in the 
cells transfected with prostasin-specific siRNA (Fig. 4B). Supporting these results, LPS-
stimulated mRNA expression of inflammatory cytokines (TNF, IL-1, IL-6 and 
CXCL1) was significantly enhanced in the cells transfected with prostasin-specific 
siRNA compared to the cells transfected with control siRNA (Fig. 4C).  
 To confirm the possibility that LPS-stimulated TLR4 activation is involved in 
the exacerbation of DSS colitis in PRSS8ΔIEC mice, PRSS8ΔIEC mice were given a 
combination of broad-spectrum antibiotics in their drinking water for 4 weeks prior to 
DSS administration in order to deplete the commensal microflora. As shown in Fig. 5, 
there was no difference in body weight loss, disease activity or histological score between 
antibiotics-treated PRSS8ΔIEC DSS mice and PRSS8 lox/lox DSS mice. Thus, antibiotics 
treatment completely suppressed the exacerbation of DSS colitis in PRSS8ΔIEC mice, 
suggesting a major role of commensal microflora-stimulated TLR-4 signaling in the 
exacerbation of DSS colitis in PRSS8ΔIEC mice.  
 Increased mucosal permeability is one of the initiating and promoting factors for 
mucosal inflammation. Previous studies have demonstrated that DSS treatment induces a 
disruption of the tight junction and increases epithelial permeability (28, 29). So, we 
evaluated the changes in mRNA expression of tight junction proteins such as zonula 
occludens-1 (ZO-1), occludin, and claudin-1 in PRSS8ΔIEC mice (29). As shown in Fig. 
6A, there was no significant difference in the mRNA expression of tight junction proteins 
between PRSS8 lox/lox and PRSS8ΔIEC mice. DSS treatment induced a significant decrease 
in the mRNA expression of ZO-1, occludin and claudin-1 in both PRSS8 lox/lox and 
PRSS8ΔIEC mice, but there was no difference in mRNA expression of these genes between 
DSS-treated PRSS8 lox/lox and DSS-treated PRSS8ΔIEC mice. Furthermore, we evaluated the 
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changes in mucosal permeability using FITC-dextran. Deletion of prostasin did not affect 
mucosal permeability, since there was no difference in serum FITC-dextran levels 
between PRSS lox/lox mice and PRSS8ΔIEC mice. Serum FITC-dextran levels were 
significantly increased in response to DSS treatment in both PRSS8 lox/lox and PRSS8ΔIEC 
mice, but there was no statistically significant difference between the two groups. These 
observations indicate that disruption of the tight junction and increased mucosal 
permeability were not involved in the exacerbation of DSS-colitis in PRSS8ΔIEC mice.  
 
Discussion 
In the present study, we demonstrated several novel findings. The first is that prostasin 
expression is markedly reduced in the inflamed mucosa of UC and CD patients. The 
second is that mice with targeted deletion of prostasin in intestinal epithelial cells 
(PRSS8ΔIEC mice) were more susceptible to DSS administration. The third is that deletion 
of prostasin lead to a marked increase in TLR4 expression and NF-B activation in 
colonic epithelial cells. Finally, mucosal permeability in PRSS8ΔIEC mice was comparable 
to that in control PRSS8 lox/lox mice. These observations suggest the presence of 
dysregulated anti-inflammatory activity in the inflamed mucosa of IBD patients due to 
down-regulation of epithelial expression of prostasin.   
 The major process of sodium absorption in human distal colon is ENaC-
mediated electrogenic sodium transport (5, 6). Previous studies have reported an impaired 
sodium absorption via altered ENaC in the inflamed mucosa of UC and CD patients, 
suggesting that impaired sodium absorption may be one of the factors that causes diarrhea 
in IBD patients (11, 12). Prostasin plays a crucial role in full activation of ENaC via 
proteolytic cleavage of the ENaC -chain (4), and deletion of prostasin in animals leads 
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to a marked disturbance of electrogenic sodium transport in the colon (7). Although there 
are a growing number of reports of basic research on prostasin (4), the pathophysiological 
role of prostasin in health and disease has not yet been fully elucidated. In this study, we 
demonstrated for the first time that prostasin expression is markedly reduced in the 
inflamed mucosa of IBD patients. This suggests that reduced prostasin expression may 
be one of the molecular mechanisms contributing to impaired ENaC-mediated 
electrogenic sodium absorption in IBD patients. In addition, these observations inspired 
us to investigate the pathological significance of reduced prostasin expression in IBD. 
 Keppner et al. previously reported that hairless (frCR) rats harboring a 
spontaneous mutation of the prostasin gene showed a reduced number of crypt and goblet 
cells and local inflammation with mild edema in the colon (30). These rats showed 
diarrhea but maintained mucosal permeability (30). Conversely, PRSS8ΔIEC mice in this 
study exhibited normal appearance and normal colon. In PRSS8ΔIEC mice, there were no 
histological signs of colitis and no abnormalities of intestinal permeability assessed by 
using FITC-dextran. These phenotypes of PRSS8ΔIEC mice were consistent with a 
previous report using similar mice (7). Thus, it became clear that prostasin deletion in 
intestinal epithelial cells itself did not directly induced mucosal inflammation, although a 
previous study revealed that colonic ENaC-mediated sodium absorption is impaired in 
these mice (7).   
 DSS treatment induced colitis in both PRSS8lox/lox and PRSS8ΔIEC mice. Colitis 
severity characterized by body weight loss, disease activity index and histological colitis 
score was significantly higher in PRSS8ΔIEC mice than in PRSS8lox/lox mice, indicating a 
protective role of prostasin in DSS colitis. Recently, Uchimura et al. reported that 
prostasin regulates hepatic insulin sensitivity by modulating TLR4 signaling (18). They 
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demonstrated that a high-fat diet triggers the suppression of prostasin expression and 
increases the TLR4 level in the liver (18). Based on this report, we evaluated TLR4 
expression in PRSS8lox/lox and PRSS8ΔIEC mice. Mucosal expression of TLR4 was 
increased in PRSS8ΔIEC mice compared to PRSS8lox/lox mice and in DSS-treated PRSS8ΔIEC 
mice compared to DSS-treated PRSS8lox/lox mice, respectively. Reflecting increased TLR4 
expression, NF-B activation and the mRNA expression of pro-inflammatory cytokines 
were significantly increased in epithelial cells isolated from PRSS8ΔIEC mice compared to 
those isolated from PRSS8lox/lox mice. Furthermore, silencing of the prostasin gene in the 
colonic epithelial cell line HT-29 using PRSS8-specific siRNA showed a direct 
suppressive effect of prostasin on TLR4 expression. These results indicate that prostasin 
has an anti-inflammatory effect via downregulation of TLR4 expression in colonic 
epithelial cells. It is likely that reduced expression of epithelial prostasin expression in 
IBD mucosa might be one of the promoting factors of mucosal inflammation via increased 
TLR4 signaling.  
    To evaluate a contribution of TLR4 signaling to exacerbation of DSS colitis in 
PRSS8ΔIEC mice, PRSS8ΔIEC mice were given a combination of broad-spectrum antibiotics 
in their drinking water for 2–4 weeks prior to DSS administration in order to deplete the 
commensal flora. This treatment has been reported to induce the sterility of the colons by 
bacteriologic analysis of fecal contents (26). As shown in Fig. 5, treatment with antibiotics 
completely abolished the exacerbation of DSS colitis in PRSS8ΔIEC mice, indicating that 
an increased TLR4 signaling in response to commensal flora was a major factor 
contributing to exacerbation of colitis in PRSS8ΔIEC mice.  
 The molecular mechanism underlying down-regulation of TLR4 by prostasin 
remains unclear. Uchiyama et al. previously demonstrated that in HepG2 cells 
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overexpressing TLR4, prostasin cleaves TLR4 by its serine protease activity and releases 
the ectodomain of TLR4 into the culture supernatant (18). A similar post-translational 
mechanism might be involved in our system, because TLR4 mRNA expression was 
equally detected in HT-29 cells with or without prostasin gene-silencing. Further 
experiments using intestinal epithelial cells overexpressing TLR4 may be helpful for 
identifying the mechanism of prostasin-mediated down-regulation of TLR4.  
There were other possible reasons for the exacerbation of DSS-colitis in 
PRSS8ΔIEC mice, including increased mucosal permeability after disruption of the 
epithelial barrier. To address this possibility, we checked mucosal mRNA expression of 
tight junction proteins. DSS treatment induced a significant decrease in mRNA expression 
of tight junction proteins in both PRSS8lox/lox and PRSS8ΔIEC mice. However, there was no 
significant difference in decreased mRNA expression of these proteins between DSS-
treated PRSS8lox/lox mice and DSS-treated PRSS8ΔIEC mice. Furthermore, mucosal 
permeability was assessed by oral administration of FITC-dextran. DSS treatment 
induced a significant increase in mucosal permeability in both PRSS8lox/lox and PRSS8ΔIEC 
mice, but there was no significant difference in increased mucosal permeability between 
DSS-treated PRSS8lox/lox mice and DSS-treated PRSS8ΔIEC mice. These findings indicated 
that increased mucosal permeability did not contribute to exacerbation of DSS colitis in 
PRSS8ΔIEC mice. 
 In conclusion, we found that expression of sodium absorption stimulator 
prostasin is markedly downregulated in the inflamed mucosa of IBD patients. From the 
observations in PRSS8ΔIEC DSS mice, it became clear that prostasin has a strong anti-
inflammatory effect via downregulation of TLR4 expression in colonic epithelial cells. 
So, a reduced prostasin expression in IBD mucosa appears to lead to a weakening of local 
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anti-inflammatory activity and may contribute to the persistence of mucosal inflammation. 
Finally, precise molecular mechanisms controlling prostasin expression at the 
inflammatory sites should be investigated in the future.  
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Fig. 1 Prostasin expression in IBD mucosa. (A) The mRNA expression of prostasin in 
colonic mucosa of patients with IBD. Prostasin mRNA was evaluated in biopsy samples 
using real-time PCR. The mRNA expression of prostasin was calculated relative to the 
mRNA expression of β-actin and shown as fold increase compared to normal mucosa. 
The data are expressed as means ±SEM (normal n=14, UC inactive n=12, UC active 
n=13, CD inactive n=12, CD active n=13). Values not sharing a letter are significantly 
different (P<0.05). (B) Immunohistochemical analyses of prostasin expression. 
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Representative pictures in normal mucosa and inflamed mucosa of active UC and CD 
patients are presented. Control IgG staining are presented. Original magnification: 
×200.  
 
Fig. 2 DSS-colitis in mice lacking prostasin specifically in intestinal epithelial cells 
(PRSS8ΔIEC mice). Experimental colitis was induced by oral administration of 4% w/v 
DSS (M.W. 5000) for 4 days and followed by 3 days water in control PRSS8lox/lox and 
PRSS8ΔIEC mice. (A) Changes in relative body weight (n=5 of each group). Values not 
sharing a letter are significantly different (P<0.05). (B) Disease activity index. (C) 
Representative microscopic pictures of the distal colon on day 7 (original 
magnification×200). (D) Histological score. The data are shown as mean ± SEM (n=5). 
Values not sharing a letter are significantly different (P<0.05).  
 
Fig. 3 TLR4 expression in control PRSS8lox/lox and PRSS8ΔIEC mice.  
(A) Immunohistochemical staining for TLR4 in control PRSS8lox/lox and PRSS8ΔIEC 
mice. TLR4 (red fluorescence) and nucleus (DAPI, blue fluorescence). Representative 
pictures from four independent experiments. (B) Immunoblot analyses of TLR4 in the 
isolated colonic epithelial cells from mice. Representative pictures from three 
independent experiments. (C) Immunoblot analyses for phosphorylated (p)-IκBα in the 
cytoplasm and NF-κBp65 in the nucleus of isolated colonic epithelial cells from mice. 
GAPDH and laminin were used as a loading control. Representative picture from three 
independent experiments. (D) Real-time PCR analyses for mucosal mRNA expression 
of TNF-α, IL-1β, IL-6 and CXCL1. Relative mRNA expression of cytokines to that of 
β-actin was calculated and presented as fold increase. The data are expressed as means 
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± SEM (n= 5). Values not sharing a letter are significantly different (P<0.05). 
 
Fig. 4 Effects of prostasin siRNA on TLR4 expression in HT-29 cells. 
(A) (Left panel) Immunoblot analyses of TLR4 and prostasin (PRSS8) in HT-29 cells 
transfected with control and prostasin-specific siRNA. The pictures are representative of 
three independent experiments. (Right panel) TLR4 mRNA expression in HT-29 cells 
transfected with control or prostasin-specific siRNA. Relative mRNA expression of 
TLR4 to that of β-actin was calculated and presented as fold increase. The data are 
expressed as means ± SEM (n=5). N.S., not significant. (B) (Upper panel) Immunoblot 
analyses of phosphorylated(p)-IκBα in the cytoplasm of the cells stimulated with LPS 
for 15min. GAPDH was used as the loading control. (Lower panel) Immunoblot 
analyses for NF-B p65 in the nucleus. Lamin A/C was used as a loading control in the 
nuclear protein. The pictures are representative of two independent experiments. (C) 
The mRNA expression for TNF-α, IL-1β, IL-6 and CXCL-1 was evaluated by real-time 
PCR. HT-29 cells were transfected with control or prostasin (PRSS8) siRNA and 
stimulated with LPS for 12h. Relative mRNA expression of cytokines to that of β-actin 
was calculated and presented as fold increase. The data are expressed as means ± SEM 
(n=5). Values not sharing a letter are significantly different (P < 0.05). 
 
Fig.5 Effects of antibiotics treatment on the development of colitis in PRSS8ΔIEC 
mice. (A) Relative body weight change. PRSS8ΔIEC mice were given a combination of 
broad-spectrum antibiotics (see Materials and Methods section) in their drinking water 
for 4 weeks prior to DSS administration (n= 5). (B) Disease activity index on day7. 
N.S.: not significant. (C and D) Representative microscopic pictures of HE-staining of 
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the distal colon (original magnification×200) and histological score. (n= 5). N.S.: not 
significant.  
 
Fig. 6. Changes in the mRNA expression of tight junction proteins and mucosal 
permeability using fluorescein isothiocyanate (FITC)-labeled dextran. (A) The 
mRNA expression for ZO-1, occludin, and claudin1 was evaluated by real-time PCR in 
colonic epithelial cells isolated from mice. Relative mRNA expression of tight junction 
proteins to that of β-actin was calculated and presented as fold increase. The data are 
expressed as means ± SEM (n=5). Values not sharing a letter are significantly different 
(P < 0.05). (B) Mice were orally administered FITC-dextran (4.4mg/10g body weight). 
After 4 hours serum fluorescence intensity was determined. The data are expressed as 
means ± SEM (n= 5). Values not sharing a letter are significantly different (P<0.05).  
 
 
